Koyfin Home > Directory > Health Care > Aeglea Biothera > Gross Margin

Aeglea Biothera Gross Margin Chart (AGLE)

Aeglea Biothera annual/quarterly Gross Margin from 2015 to 2018. Gross margin is a company's total sales revenue minus its cost of goods sold (COGS), divided by total sales revenue, expressed as a percentage. The higher the percentage, the more the company retains on each dollar of sales, to service its other costs and debt obligations.
  • Aeglea Biothera Gross Margin for the quarter ending June 06, 2018 was $-284m a -39.20% increase of 111m year over year
  • Aeglea Biothera Gross Margin for the last 12 months ending March 03, 2019 was $-1,760m a 81.67% decrease of -1,438m year over year
  • Aeglea Biothera Annual Gross Margin for 2018 was $-844m a 59.93% decrease of -506m from 2017
  • Aeglea Biothera Annual Gross Margin for 2017 was $-338m a 13.69% decrease of -46m from 2016
  • Aeglea Biothera Annual Gross Margin for 2016 was $-292m a 69.79% decrease of -204m from 2015
Other Margins & Efficiency Metrics:
  • Aeglea Biothera EBITDA Margin for the quarter ending December 12, 2015 was $-251m
  • Aeglea Biothera Return on Capital % for the quarter ending September 09, 2018 was -44.64 a 29.88% decrease of -13.34 year over year
  • Aeglea Biothera Return on Equity % for the quarter ending September 09, 2018 was -69.52 a 29.52% decrease of -20.52 year over year
View Chart On Koyfin

Quarterly AGLE Gross Margin Data

06/2018$-284m
03/2018$-355m
12/2017$-291m
09/2017$-395m
06/2017$-295m
03/2017$-404m
12/2016$-280m
09/2016$-369m
06/2016$-222m
03/2016$-319m

Annual AGLE Gross Margin Data

2018$-844m
2017$-338m
2016$-292m
2015$-88m